Sarepta Therapeutics Inc (SRPT)
Operating profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 218,081 | 81,025 | 37,987 | -94,831 | -267,824 | -399,282 | -509,795 | -587,408 | -536,201 | -535,181 | -438,284 | -394,726 | -459,710 | -524,613 | -627,223 | -598,002 | -564,163 | -623,666 | -610,188 | -747,202 |
| Revenue (ttm) | US$ in thousands | 1,901,979 | 1,640,348 | 1,504,993 | 1,403,300 | 1,243,336 | 1,104,982 | 1,003,434 | 975,683 | 933,013 | 876,047 | 835,184 | 765,786 | 701,887 | 645,564 | 600,082 | 573,356 | 540,099 | 495,074 | 450,191 | 407,496 |
| Operating profit margin | 11.47% | 4.94% | 2.52% | -6.76% | -21.54% | -36.13% | -50.81% | -60.20% | -57.47% | -61.09% | -52.48% | -51.55% | -65.50% | -81.26% | -104.52% | -104.30% | -104.46% | -125.97% | -135.54% | -183.36% |
December 31, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $218,081K ÷ $1,901,979K
= 11.47%
Sarepta Therapeutics Inc's operating profit margin has shown a consistent improvement over the period from March 31, 2020, to December 31, 2024. Starting at a significantly negative level of -183.36% in March 2020, the company managed to reduce its operating losses gradually over time.
The operating profit margin continued to improve, reaching positive territory and turning into a profit margin of 11.47% by the end of December 31, 2024. This turnaround indicates that Sarepta Therapeutics Inc has effectively managed its operational efficiency and profitability, ultimately achieving a positive return on its operating activities.
Peer comparison
Dec 31, 2024